1. Home
  2. OCEAW vs CCIA Comparison

OCEAW vs CCIA Comparison

Compare OCEAW & CCIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCEAW
  • CCIA
  • Stock Information
  • Founded
  • OCEAW N/A
  • CCIA N/A
  • Country
  • OCEAW United States
  • CCIA
  • Employees
  • OCEAW 9
  • CCIA N/A
  • Industry
  • OCEAW Biotechnology: Pharmaceutical Preparations
  • CCIA
  • Sector
  • OCEAW Health Care
  • CCIA
  • Exchange
  • OCEAW Nasdaq
  • CCIA Nasdaq
  • Market Cap
  • OCEAW N/A
  • CCIA N/A
  • IPO Year
  • OCEAW 2021
  • CCIA 2023
  • Fundamental
  • Price
  • OCEAW $0.03
  • CCIA $26.50
  • Analyst Decision
  • OCEAW
  • CCIA
  • Analyst Count
  • OCEAW 0
  • CCIA 0
  • Target Price
  • OCEAW N/A
  • CCIA N/A
  • AVG Volume (30 Days)
  • OCEAW N/A
  • CCIA N/A
  • Earning Date
  • OCEAW N/A
  • CCIA N/A
  • Dividend Yield
  • OCEAW N/A
  • CCIA N/A
  • EPS Growth
  • OCEAW N/A
  • CCIA N/A
  • EPS
  • OCEAW N/A
  • CCIA N/A
  • Revenue
  • OCEAW N/A
  • CCIA N/A
  • Revenue This Year
  • OCEAW N/A
  • CCIA N/A
  • Revenue Next Year
  • OCEAW N/A
  • CCIA N/A
  • P/E Ratio
  • OCEAW N/A
  • CCIA N/A
  • Revenue Growth
  • OCEAW N/A
  • CCIA N/A
  • 52 Week Low
  • OCEAW N/A
  • CCIA N/A
  • 52 Week High
  • OCEAW N/A
  • CCIA N/A
  • Technical
  • Relative Strength Index (RSI)
  • OCEAW N/A
  • CCIA 61.11
  • Support Level
  • OCEAW N/A
  • CCIA $26.12
  • Resistance Level
  • OCEAW N/A
  • CCIA $26.94
  • Average True Range (ATR)
  • OCEAW 0.00
  • CCIA 0.29
  • MACD
  • OCEAW 0.00
  • CCIA -0.01
  • Stochastic Oscillator
  • OCEAW 0.00
  • CCIA 33.51

About OCEAW Ocean Biomediacal Inc.

Ocean Biomedical Inc is a biopharmaceutical company. It is dedicated towards partnering with inventor-scientists and research institutes to bridge the gap between basic research and clinical development, to get new medicines to the patients who need it most.

About CCIA Carlyle Credit Income Fund 8.75% Series A Preferred Shares due 2028

Carlyle Credit Income Fund is a non-diversified, closed-end management investment company. The Fund's primary investment objective is to generate current income, with a secondary objective to generate capital appreciation. The Fund seeks to achieve its investment objective by investing predominantly in equity and junior debt tranches of collateralized loan obligations, that are collateralized by a portfolio consisting mainly of below-investment-grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.

Share on Social Networks: